AAPL348.51-2.18 (-0.62%) ▼|ABBV293.89+0.59 (+0.20%) ▲|ABT110.46-0.05 (-0.05%) ▼|ACN258.51+4.14 (+1.63%) ▲|ADBE236.70-0.62 (-0.26%) ▼|AMAT372.53+1.98 (+0.53%) ▲|AMD515.21+6.63 (+1.30%) ▲|AMGN465.23+0.00 (+0.00%) ▲|AMT190.37+1.37 (+0.72%) ▲|AMZN270.87+3.94 (+1.48%) ▲|AVGO331.98+12.50 (+3.91%) ▲|AXP323.46-0.85 (-0.26%) ▼|BA173.38+1.00 (+0.58%) ▲|BAC50.68+0.13 (+0.26%) ▲|BKNG159.26-4.23 (-2.59%) ▼|BLK1,222.15+7.44 (+0.61%) ▲|BMY62.80+0.66 (+1.06%) ▲|BNY151.14-0.09 (-0.06%) ▼|BRK-B583.34+8.09 (+1.41%) ▲|C122.27+0.30 (+0.25%) ▲|CAT584.57-14.31 (-2.39%) ▼|CL98.09+0.15 (+0.15%) ▲|CMCSA24.75+0.24 (+0.98%) ▲|COF195.84-2.74 (-1.38%) ▼|COP135.59+1.12 (+0.83%) ▲|COST1,066.14-0.04 (0.00%) ▼|CRM213.48-1.46 (-0.68%) ▼|CSCO98.15-0.50 (-0.51%) ▼|CVS89.01+3.76 (+4.41%) ▲|CVX211.22+0.44 (+0.21%) ▲|DE687.64-3.64 (-0.53%) ▼|DHR236.11+0.99 (+0.42%) ▲|DIS119.21+0.09 (+0.08%) ▲|DUK128.94+0.84 (+0.66%) ▲|EMR167.54-1.98 (-1.17%) ▼|FDX319.48+0.64 (+0.20%) ▲|GD367.44+5.37 (+1.48%) ▲|GE337.91+2.37 (+0.71%) ▲|GEV797.04-32.30 (-3.89%) ▼|GILD170.87+1.55 (+0.92%) ▲|GM88.69-0.96 (-1.07%) ▼|GOOG284.92-1.09 (-0.38%) ▼|GOOGL287.38-0.77 (-0.27%) ▼|GS910.19+3.97 (+0.44%) ▲|HD351.00-2.42 (-0.68%) ▼|HON228.22-0.78 (-0.34%) ▼|IBM244.53+0.11 (+0.05%) ▲|INTC58.13-1.24 (-2.09%) ▼|INTU340.44+2.21 (+0.65%) ▲|ISRG450.04-10.52 (-2.28%) ▼|JNJ280.78-1.33 (-0.47%) ▼|JPM342.07-0.01 (0.00%) ▼|KO96.91+0.88 (+0.92%) ▲|LIN521.78+1.45 (+0.28%) ▲|LLY1,432.29+20.34 (+1.44%) ▲|LMT603.12+14.93 (+2.54%) ▲|LOW231.87-0.23 (-0.10%) ▼|LRCX222.39+1.08 (+0.49%) ▲|MA658.84+3.03 (+0.46%) ▲|MCD282.17+0.73 (+0.26%) ▲|MDLZ66.54+0.10 (+0.15%) ▲|MDT101.59-1.20 (-1.17%) ▼|META641.39+0.02 (+0.00%) ▲|MMM189.37+0.74 (+0.39%) ▲|MO76.34+0.53 (+0.70%) ▲|MRK148.05-0.71 (-0.48%) ▼|MS187.56+0.46 (+0.25%) ▲|MSFT533.16-12.02 (-2.20%) ▼|MU725.11-8.04 (-1.10%) ▼|NEE86.27-0.59 (-0.68%) ▼|NFLX63.26-0.69 (-1.08%) ▼|NKE38.67-1.21 (-3.03%) ▼|NOW99.61-3.15 (-3.07%) ▼|NVDA168.89-9.78 (-5.47%) ▼|ORCL117.98-1.81 (-1.51%) ▼|PEP143.61+1.73 (+1.22%) ▲|PFE29.36+0.13 (+0.44%) ▲|PG168.66+0.34 (+0.20%) ▲|PLTR168.82-0.38 (-0.22%) ▼|PM194.25+1.13 (+0.59%) ▲|QCOM173.53+2.06 (+1.20%) ▲|RTX200.27+3.96 (+2.02%) ▲|SBUX109.95+0.51 (+0.47%) ▲|SCHW93.03+0.30 (+0.32%) ▲|SO93.65+0.08 (+0.09%) ▲|SPG234.48+1.47 (+0.63%) ▲|T21.94+0.14 (+0.64%) ▲|TMO718.20-3.43 (-0.48%) ▼|TMUS169.08+0.37 (+0.22%) ▲|TSLA379.78+1.73 (+0.46%) ▲|TXN300.52+4.79 (+1.62%) ▲|UBER70.05-1.12 (-1.57%) ▼|UNH405.12+7.50 (+1.89%) ▲|UNP300.62+3.61 (+1.22%) ▲|UPS111.05+0.09 (+0.08%) ▲|USB60.75-0.20 (-0.33%) ▼|V423.00+1.62 (+0.38%) ▲|VZ46.31+0.25 (+0.54%) ▲|WFC85.76+0.27 (+0.32%) ▲|WMT125.55-0.11 (-0.09%) ▼|XOM164.47-0.26 (-0.16%) ▼|AAPL348.51-2.18 (-0.62%) ▼|ABBV293.89+0.59 (+0.20%) ▲|ABT110.46-0.05 (-0.05%) ▼|ACN258.51+4.14 (+1.63%) ▲|ADBE236.70-0.62 (-0.26%) ▼|AMAT372.53+1.98 (+0.53%) ▲|AMD515.21+6.63 (+1.30%) ▲|AMGN465.23+0.00 (+0.00%) ▲|AMT190.37+1.37 (+0.72%) ▲|AMZN270.87+3.94 (+1.48%) ▲|AVGO331.98+12.50 (+3.91%) ▲|AXP323.46-0.85 (-0.26%) ▼|BA173.38+1.00 (+0.58%) ▲|BAC50.68+0.13 (+0.26%) ▲|BKNG159.26-4.23 (-2.59%) ▼|BLK1,222.15+7.44 (+0.61%) ▲|BMY62.80+0.66 (+1.06%) ▲|BNY151.14-0.09 (-0.06%) ▼|BRK-B583.34+8.09 (+1.41%) ▲|C122.27+0.30 (+0.25%) ▲|CAT584.57-14.31 (-2.39%) ▼|CL98.09+0.15 (+0.15%) ▲|CMCSA24.75+0.24 (+0.98%) ▲|COF195.84-2.74 (-1.38%) ▼|COP135.59+1.12 (+0.83%) ▲|COST1,066.14-0.04 (0.00%) ▼|CRM213.48-1.46 (-0.68%) ▼|CSCO98.15-0.50 (-0.51%) ▼|CVS89.01+3.76 (+4.41%) ▲|CVX211.22+0.44 (+0.21%) ▲|DE687.64-3.64 (-0.53%) ▼|DHR236.11+0.99 (+0.42%) ▲|DIS119.21+0.09 (+0.08%) ▲|DUK128.94+0.84 (+0.66%) ▲|EMR167.54-1.98 (-1.17%) ▼|FDX319.48+0.64 (+0.20%) ▲|GD367.44+5.37 (+1.48%) ▲|GE337.91+2.37 (+0.71%) ▲|GEV797.04-32.30 (-3.89%) ▼|GILD170.87+1.55 (+0.92%) ▲|GM88.69-0.96 (-1.07%) ▼|GOOG284.92-1.09 (-0.38%) ▼|GOOGL287.38-0.77 (-0.27%) ▼|GS910.19+3.97 (+0.44%) ▲|HD351.00-2.42 (-0.68%) ▼|HON228.22-0.78 (-0.34%) ▼|IBM244.53+0.11 (+0.05%) ▲|INTC58.13-1.24 (-2.09%) ▼|INTU340.44+2.21 (+0.65%) ▲|ISRG450.04-10.52 (-2.28%) ▼|JNJ280.78-1.33 (-0.47%) ▼|JPM342.07-0.01 (0.00%) ▼|KO96.91+0.88 (+0.92%) ▲|LIN521.78+1.45 (+0.28%) ▲|LLY1,432.29+20.34 (+1.44%) ▲|LMT603.12+14.93 (+2.54%) ▲|LOW231.87-0.23 (-0.10%) ▼|LRCX222.39+1.08 (+0.49%) ▲|MA658.84+3.03 (+0.46%) ▲|MCD282.17+0.73 (+0.26%) ▲|MDLZ66.54+0.10 (+0.15%) ▲|MDT101.59-1.20 (-1.17%) ▼|META641.39+0.02 (+0.00%) ▲|MMM189.37+0.74 (+0.39%) ▲|MO76.34+0.53 (+0.70%) ▲|MRK148.05-0.71 (-0.48%) ▼|MS187.56+0.46 (+0.25%) ▲|MSFT533.16-12.02 (-2.20%) ▼|MU725.11-8.04 (-1.10%) ▼|NEE86.27-0.59 (-0.68%) ▼|NFLX63.26-0.69 (-1.08%) ▼|NKE38.67-1.21 (-3.03%) ▼|NOW99.61-3.15 (-3.07%) ▼|NVDA168.89-9.78 (-5.47%) ▼|ORCL117.98-1.81 (-1.51%) ▼|PEP143.61+1.73 (+1.22%) ▲|PFE29.36+0.13 (+0.44%) ▲|PG168.66+0.34 (+0.20%) ▲|PLTR168.82-0.38 (-0.22%) ▼|PM194.25+1.13 (+0.59%) ▲|QCOM173.53+2.06 (+1.20%) ▲|RTX200.27+3.96 (+2.02%) ▲|SBUX109.95+0.51 (+0.47%) ▲|SCHW93.03+0.30 (+0.32%) ▲|SO93.65+0.08 (+0.09%) ▲|SPG234.48+1.47 (+0.63%) ▲|T21.94+0.14 (+0.64%) ▲|TMO718.20-3.43 (-0.48%) ▼|TMUS169.08+0.37 (+0.22%) ▲|TSLA379.78+1.73 (+0.46%) ▲|TXN300.52+4.79 (+1.62%) ▲|UBER70.05-1.12 (-1.57%) ▼|UNH405.12+7.50 (+1.89%) ▲|UNP300.62+3.61 (+1.22%) ▲|UPS111.05+0.09 (+0.08%) ▲|USB60.75-0.20 (-0.33%) ▼|V423.00+1.62 (+0.38%) ▲|VZ46.31+0.25 (+0.54%) ▲|WFC85.76+0.27 (+0.32%) ▲|WMT125.55-0.11 (-0.09%) ▼|XOM164.47-0.26 (-0.16%) ▼|
13 C
New York
Wednesday, November 11, 2026

Tag: year

newsFORsourcecompanycontentinformationreleases1IT

Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items required for filing a Biologics License Application (BLA) for Revascor® (rexlemestrocel-L) in the treatment of patients with ischemic heart failure with reduced ejection fraction (HFrEF) and inflammation.

More than 341,000 Families Reached: ADD MILK! Campaign Celebrates a Year of Healthier Choices and Stronger Communities 

ADD MILK! celebrates 1 year of increasing access to low-fat milk for SNAP families, reaching 341K households and expanding to 1,100+ stores nationwide.

Kavalan Blitzes IWC 2025 Taking Trio of Whisky, Distillery and Master Distiller of the Year Prizes

Judges say Kavalan's Solist Fino Sherry 'stunned' panel with balance and complexity TAIPEI, July 1, 2025 /PRNewswire/ -- Kavalan has come away from the 16th...

KARNALYTE RESOURCES INC. ANNOUNCES ANNUAL AND SPECIAL MEETING VOTING RESULTS

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ SASKATOON, SK, June 30, 2025 /CNW/ - Karnalyte Resources Inc. ("Karnalyte" or...

VITALITY ANNOUNCES FIRST QUARTER RESULTS

TSXV Trading Symbol:  VPI VANCOUVER, BC, June 30, 2025 /CNW/ - Vitality Products Inc. (TSXV: VPI) (the "Company" or "Vitality"), a manufacturer, marketer and distributor...

OLIVEDA International Inc. will bring waterless beauty to Canada in July 2025 with OLIVE TREE PEOPLE Canada Inc.

VENICE, Calif. and TORONTO, June 30, 2025 /PRNewswire/ -- After a true waterless beauty movement emerged in the US within just two year, with...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Krispy Kreme, Inc. Securities...

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

Once Insurance Partners With Retailers To Embed Jewelry Protection at Checkout

Once Insurance Group has launched embedded jewelry protection at retail checkout, offering five-year coverage with no appraisals or renewals. The digital service expands access to affordable valuables insurance and marks the company’s first U.S. retail integrations. 
Once Insurance Group has launched embedded jewelry protection at retail checkout, offering five-year coverage with no appraisals or renewals. The digital service expands access to affordable valuables insurance and marks the company’s first U.S. retail integrations.

Pet King Brands’ ZYMOX® Designated as a 2025 Vanguard Awards Winner in Eye and Ear Care

Pet Insight Magazine recognizes ZYMOX as a category trailblazer. AUSTIN, Texas, June 30, 2025 /PRNewswire/ -- Pet King Brands, a pioneering leader in veterinarian-recommended enzymatic...

Geronimo Power Hosts “Solar Summer Social” to Celebrate Apple River Solar

100-MW project located in Polk County, Wisconsin MINNEAPOLIS, June 30, 2025 /PRNewswire/ -- Last week, Geronimo Power (Geronimo) hosted a community event to celebrate the construction...

Camfil Highlights Importance of Summer HVAC Maintenance for Better Learning Environments

By leveraging the summer lull to revamp HVAC systems, while students and faculty are off-site, schools can ensure healthier and more efficient learning environments come fall. 
By leveraging the summer lull to revamp HVAC systems, while students and faculty are off-site, schools can ensure healthier and more efficient learning environments come fall.

Susie White receives San Bernardino County Medical Society President’s Award

RANCHO CUCAMONGA, Calif., June 30, 2025 /PRNewswire/ -- Inland Empire Health Plan (IEHP) Chief Operating Officer Susie White received the San Bernardino County Medical...

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action –...

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 25, 2025.

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsYear

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers